chr9-35658425-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_174923.3(CCDC107):āc.46G>Cā(p.Val16Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000226 in 1,457,124 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V16A) has been classified as Uncertain significance.
Frequency
Consequence
NM_174923.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC107 | NM_174923.3 | c.46G>C | p.Val16Leu | missense_variant | 1/5 | ENST00000426546.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC107 | ENST00000426546.7 | c.46G>C | p.Val16Leu | missense_variant | 1/5 | 1 | NM_174923.3 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000337 AC: 3AN: 89146Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 48484
GnomAD4 exome AF: 0.00000996 AC: 13AN: 1304810Hom.: 0 Cov.: 31 AF XY: 0.0000109 AC XY: 7AN XY: 641482
GnomAD4 genome AF: 0.000131 AC: 20AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.0000806 AC XY: 6AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.46G>C (p.V16L) alteration is located in exon 1 (coding exon 1) of the CCDC107 gene. This alteration results from a G to C substitution at nucleotide position 46, causing the valine (V) at amino acid position 16 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at